Development, characterization and application of an antibody against 5-fluoro-2deoxyuridine-5monophosphate, the active metabolite of 5-fluorouracilPETERS, G. J; LAURENSSE, E; STEINBUSCH, H. W. M et al.Anticancer research. 1993, Vol 13, Num 4, pp 835-839, issn 0250-7005Article

Ionization of bromouracil and fluorouracil stimulates base mispairing frequencies with guanineHONG YU; ERITJA, R; BLOOM, L. B et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 21, pp 15935-15943, issn 0021-9258Article

Crystal structure of hybrid dipeptide, cytosinyl-L-tyrosineDOI, M; MIYAKO, H; ASANO, A et al.Analytical sciences. 1999, Vol 15, Num 1, pp 109-110, issn 0910-6340Article

Mechanisms of interactions of interferon and 5-fluorouracil in solid tumorsNEEFE, J. R; JOHN, W.Seminars in oncology. 1991, Vol 18, Num 5, pp 77-82, issn 0093-7754, SUP7Article

Oxydations radicalaires photo- et radio-induites des bases puriniques et pyrimidniques des acides nucléiquesCADET, J; BERGER, M; DECARROZ, C et al.Journal de chimie physique. 1991, Vol 88, Num 6, pp 1021-1042, issn 0021-7689Article

α-interferon and 5-fluorouracil : possible mechanisms of antitumor actionMEADOWS, L. M; WALTHER, P; OZER, H et al.Seminars in oncology. 1991, Vol 18, Num 5, pp 71-76, issn 0093-7754, SUP7Article

On the inhibition of deoxycytidylate hydroxymethylase by 5-fluoro-2'-deoxycytidine 5'-monophosphateSUBRAMANIAM, R; WANG, Y; MATHEWS, C. K et al.Archives of biochemistry and biophysics (Print). 1989, Vol 275, Num 1, pp 11-15, issn 0003-9861Article

Reversed-phase high-performance liquid chromatograpy of pyrimidine bases and nucleosides: application of solvophobic theoryGALUSHKO, S. V; SHISHKINA, I. P; PILIPENKO, A. T et al.Journal of chromatography. 1988, Vol 445, Num 1, pp 59-70, issn 0021-9673Article

DFT study of the reaction proceeding in the cytidine deaminaseKEDZIERSKI, Pawel; SOKALSKI, W. Andrzej; HANSONG CHENG et al.Chemical physics letters. 2003, Vol 381, Num 5-6, pp 660-665, issn 0009-2614, 6 p.Article

Stereocontrolled synthesis of oligo(nucleoside phosphorothioate)sSTEC, W. J; WILK, A.Angewandte Chemie. International edition in English. 1994, Vol 33, Num 7, pp 709-722, issn 0570-0833Article

Bioavailability and feasibility of subcutaneous 5-fluorouracilBORNER, M. M; KNEER, J; CREVOISIER, C et al.British journal of cancer. 1993, Vol 68, Num 3, pp 537-539, issn 0007-0920Article

Synthesis of haptens and conjugates for an enzyme immunoassay for analysis of the herbicide bromacilSZURDOKI, F; BEKHEIT, H. K. M; MARCO, M.-P et al.Journal of agricultural and food chemistry (Print). 1992, Vol 40, Num 8, pp 1459-1465, issn 0021-8561Article

Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracilCASCINU, S; FEDELI, A; LUZI FEDELI, S et al.European journal of cancer (1990). 1992, Vol 28, Num 2-3, pp 482-483, issn 0959-8049Conference Paper

The pharmacokinetics of 5-fluorouracil administered by arterial infusion in advanced colorectal hepatic metastasesGOLDBERG, J. A; KERR, D. J; WATSON, D. G et al.British journal of cancer. 1990, Vol 61, Num 6, pp 913-915, issn 0007-0920, 3 p.Article

Thymineless death in angrogen-independent prostatic cancer cellsKYPRIANOU, N; ISSACS, J. T.Biochemical and biophysical research communications (Print). 1989, Vol 165, Num 1, pp 73-81, issn 0006-291XArticle

Pharmaceutical analysis using micellar electrokinetic capillary chromatographySWAILE, D. F; BURTON, D. E; BALCHUNAS, A. T et al.Journal of chromatographic science. 1988, Vol 26, Num 8, pp 406-409, issn 0021-9665Article

Investigation into the scope and limitations of molecular imprinting with DNA moleculesSPIVAK, David A; SHEA, Kenneth J.Analytica chimica acta. 2001, Vol 435, Num 1, pp 65-74, issn 0003-2670Conference Paper

Determination of bromacil in groundwater and in high organic matter soilsJAMES, T. K; LAUREN, D. R.Journal of agricultural and food chemistry (Print). 1995, Vol 43, Num 3, pp 684-690, issn 0021-8561Article

Effect of 5-fluorouracil on secretion and synthesis of pancreatic digestive enzymes : studies in isolated pancreatic acini and perfused pacreas derived from normal rats and from rats with acute necrotizing pancreatitisBIELECKI, K; WIEDMANN, M; MEYER, F et al.Pancreas. 1994, Vol 9, Num 4, pp 518-525, issn 0885-3177Article

Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations : a comparative study using cisplatin and carboplatinFOURNIER, C; HECQUET, B; BASTIAN, G et al.Cancer chemotherapy and pharmacology. 1992, Vol 29, Num 6, pp 461-466, issn 0344-5704Article

Gas chromatography-mass spectrometry of free radical-induced products of pyrimidines and purines in DNADIZDAROGLU, M.Methods in enzymology. 1990, Vol 193, pp 842-857, issn 0076-6879, 1Article

ENDOR study of a thiocytosine oxidation product in cytosine monohydrate crystals doped with 2-thiocytosine, X-irradiated at 15 KHERAK, Janko N; SANKOVIC, Kresimir; HOLE, Eli O et al.PCCP. Physical chemistry chemical physics (Print). 2000, Vol 2, Num 21, pp 4971-4975, issn 1463-9076Article

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatmentCOMANDONE, A; BRETTI, S; LA GROTTA, G et al.Anticancer research. 1993, Vol 13, Num 5C, pp 1781-1783, issn 0250-7005Article

Synthesis and antitumor activity of poly(ethylene glycol)s linked to 5-fluorouracil via a urethane or urea bondOUCHI, T; HAGIHARA, Y; TAKAHASHI, K et al.Drug design and discovery (Print). 1992, Vol 9, Num 1, pp 93-105, issn 1055-9612Article

Systemic therapy for colorectal cancer : an overviewMAYER, R. J.Seminars in oncology. 1991, Vol 18, Num 5, pp 62-66, issn 0093-7754, SUP7Article